A generative-discriminative framework that integrates imaging, genetic, and diagnosis into coupled low dimensional space.


Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
09 2021
Historique:
received: 28 09 2020
revised: 08 04 2021
accepted: 22 05 2021
pubmed: 13 6 2021
medline: 21 10 2021
entrez: 12 6 2021
Statut: ppublish

Résumé

We propose a novel optimization framework that integrates imaging and genetics data for simultaneous biomarker identification and disease classification. The generative component of our model uses a dictionary learning framework to project the imaging and genetic data into a shared low dimensional space. We have coupled both the data modalities by tying the linear projection coefficients to the same latent space. The discriminative component of our model uses logistic regression on the projection vectors for disease diagnosis. This prediction task implicitly guides our framework to find interpretable biomarkers that are substantially different between a healthy and disease population. We exploit the interconnectedness of different brain regions by incorporating a graph regularization penalty into the joint objective function. We also use a group sparsity penalty to find a representative set of genetic basis vectors that span a low dimensional space where subjects are easily separable between patients and controls. We have evaluated our model on a population study of schizophrenia that includes two task fMRI paradigms and single nucleotide polymorphism (SNP) data. Using ten-fold cross validation, we compare our generative-discriminative framework with canonical correlation analysis (CCA) of imaging and genetics data, parallel independent component analysis (pICA) of imaging and genetics data, random forest (RF) classification, and a linear support vector machine (SVM). We also quantify the reproducibility of the imaging and genetics biomarkers via subsampling. Our framework achieves higher class prediction accuracy and identifies robust biomarkers. Moreover, the implicated brain regions and genetic variants underlie the well documented deficits in schizophrenia.

Identifiants

pubmed: 34118398
pii: S1053-8119(21)00477-8
doi: 10.1016/j.neuroimage.2021.118200
pii:
doi:

Substances chimiques

Genetic Markers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

118200

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Sayan Ghosal (S)

Department of Electrical and Computer Engineering, Johns Hopkins University, USA. Electronic address: sghosal3@jhu.edu.

Qiang Chen (Q)

Lieber Institute for Brain Development, USA.

Giulio Pergola (G)

Lieber Institute for Brain Development, USA; Group of Psychiatric Neuroscience, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Aaron L Goldman (AL)

Lieber Institute for Brain Development, USA.

William Ulrich (W)

Lieber Institute for Brain Development, USA.

Karen F Berman (KF)

Clinical and Translational Neuroscience Branch, NIMH, NIH, USA.

Giuseppe Blasi (G)

Group of Psychiatric Neuroscience, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy; Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy.

Leonardo Fazio (L)

Group of Psychiatric Neuroscience, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy; 4IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy.

Antonio Rampino (A)

Group of Psychiatric Neuroscience, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy; Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy.

Alessandro Bertolino (A)

Group of Psychiatric Neuroscience, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy; Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy.

Daniel R Weinberger (DR)

Lieber Institute for Brain Development, USA; Department of Psychiatry, Neurology and Neuroscience, Johns Hopkins University School of Medicine, USA.

Venkata S Mattay (VS)

Lieber Institute for Brain Development, USA; Department of Neurology and Radiology, Johns Hopkins University School of Medicine, USA.

Archana Venkataraman (A)

Department of Electrical and Computer Engineering, Johns Hopkins University, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH